Monday, October 12, 2026

°

Asahi Kasei Acquisition Pays Off With FDA Approval for Novel Herpes Drug

Posted Monday, October 12, 2026 10:44 am

Frank Vinluan (via MedCity News)

Asahi Kasei’s Hovilpri is now approved for treating lesions caused by herpes simplex virus infection. This daily pill came from the $919 million acquisition of AiCuris Anti-Infective Cures. The post Asahi Kasei Acquisition Pays Off With FDA Approval for Novel Herpes Drug appeared first on MedCity News.

Continue reading at MedCity News »

Keywords

BioPharma, Legal, Pharma, antiviral, Asahi Kasei, biopharma nl, Clinical Trials, FDA, herpes, Herpes Simplex Virus, Japan

Top stories

Why Women Should Find Out Their Breast Cancer Risk Earlier than You Think

(NewsUSA) - For many people, breast cancer screening becomes a priority around age 40. However, according to recommendations from the American College of Radiology® (ACR®), one of the most …

Ask About Clinical Trials on Day One

(Mitch Jelniker) - For people diagnosed with small cell lung cancer, the clinical trial conversation belongs in the very first appointment.A diagnosis of SCLC can trigger a whirlwind of appointments, …

From Uncertainty to Reassurance: How a Small Heart Monitor and Ablation Procedure Helped One Father Conquer the Unknowns of Atrial Fibrillation

(NewsUSA) - In 2018, then-52-year-old Todd Repass Jr. stood up after a meal and immediately knew something was wrong. It was terrifying. He felt weak, short of breath, and, at times, dizzy. The …

Youth Tobacco Use Is at Historic Lows. Adult Smokers Still Need Better Choices.

(Dr. Matthew Holman) - There is a piece of good public health news that deserves more attention: youth tobacco use in the United States has fallen to historically low levels. That progress did not …

America’s New Drug Dealers Have Moved from Street Corners to the Internet – and the FDA is Letting Them

(Peter Pitts, President and Co-founder of the Center for Medicine in the Public Interest ) - Consumers purchasing retatrutide online may think they are buying a safe, clinically tested weight-loss …

From the web

What is a Pulmonary Embolism?

A pulmonary embolism is scary; there’s no denying that. When a blood clot gets lodged in the arteries that connect the lungs and heart, it can mean instant death—and it does for about 25 percent …

InvestorNewsBreaks – Regentis Biomaterials Ltd. (NYSE American: RGNT) Reports Strong Surgeon Interest in GelrinC at International Cartilage Summit

Regentis Biomaterials (NYSE American: RGNT), a regenerative medicine company focused on innovative tissue repair solutions, announced strong interest and engagement from orthopedic surgeons, …

NetworkNewsBreaks – Shelfie-Tech Ltd. (CSE: SHLF) (OTCQB: SHLFF) Closes CAD$1.71 Million Private Placement

This article has been disseminated on behalf of Shelfie-Tech Ltd. and may include paid advertising. Shelfie-Tech Ltd. (CSE: SHLF) (OTCQB: SHLFF) announced the closing of its previously disclosed …

Asahi Kasei Acquisition Pays Off With FDA Approval for Novel Herpes Drug

Asahi Kasei’s Hovilpri is now approved for treating lesions caused by herpes simplex virus infection. This daily pill came from the $919 million acquisition of AiCuris Anti-Infective Cures. The …

Outro Raises $7M To Support Safe Deprescribing

Outro’s funding included participation from Listen Ventures, Cake Ventures, Jason Calicanis’s LAUNCH, Actions Capital, Hannah Grey Ventures, SemperVirens, Brock Recovery Group and Pave Health …